Literature DB >> 19730442

Caspase-3-mediated secretion of connective tissue growth factor by apoptotic endothelial cells promotes fibrosis.

P Laplante1, I Sirois, M-A Raymond, V Kokta, A Béliveau, A Prat, A V Pshezhetsky, M-J Hébert.   

Abstract

Apoptosis of endothelial cells (ECs) is an early pathogenic event in various fibrotic diseases. In this study, we evaluated whether paracrine mediators produced by apoptotic ECs play direct roles in fibrogenesis. C3H mice injected subcutaneously with serum-free medium conditioned by apoptotic ECs (SSC) showed increased skin thickness and heightened protein levels of alpha-smooth-muscle actin (alphaSMA), vimentin and collagen I as compared with mice injected with medium conditioned by non-apoptotic ECs. Fibroblasts exposed to SSC in vitro showed cardinal features of myofibroblast differentiation with increased stress fiber formation and expression of alphaSMA. Caspase-3 silencing in ECs prevented the release of mediators favoring myofibroblast differentiation. To identify the fibrogenic factor(s) released by ECs, the protein contents of media conditioned by either apoptotic or non-apoptotic ECs were compared using SDS-PAGE-liquid chromatography (LC)-tandem mass spectrometry (MS/MS) and two-dimensional LC-MS/MS. Connective tissue growth factor (CTGF) was the only fibrogenic protein found increased in SSC. Pan-caspase inhibition with ZVAD-FMK or caspase-3 silencing in ECs confirmed that CTGF was released downstream of caspase-3 activation. The fibrogenic signaling signatures of SSC and CTGF on fibroblasts in vitro were similarly Pyk2-, Src-family kinases- and PI3K dependent, but TGF-beta-independent. CTGF-immunodepleted SSC failed to induce myofibroblast differentiation in vitro and skin fibrosis in vivo. These results identify caspase-3 activation in ECs as a novel inducer of CTGF release and fibrogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19730442     DOI: 10.1038/cdd.2009.124

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  32 in total

1.  Bleomycin induces endothelial mesenchymal transition through activation of mTOR pathway: a possible mechanism contributing to the sclerotherapy of venous malformations.

Authors:  Wei Zhang; Gang Chen; Jian-Gang Ren; Yi-Fang Zhao
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

2.  Induction of elastin expression in vascular endothelial cells relates to hepatoportal sclerosis in idiopathic portal hypertension: possible link to serum anti-endothelial cell antibodies.

Authors:  Y Sato; X S Ren; K Harada; M Sasaki; H Morikawa; S Shiomi; M Honda; S Kaneko; Y Nakanuma
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

3.  Dying glioma cells establish a proangiogenic microenvironment through a caspase 3 dependent mechanism.

Authors:  Xiao Feng; Yang Yu; Sijia He; Jin Cheng; Yanping Gong; Zhengxiang Zhang; Xuguang Yang; Bing Xu; Xinjian Liu; Chuan-Yuan Li; Ling Tian; Qian Huang
Journal:  Cancer Lett       Date:  2016-11-05       Impact factor: 8.679

4.  Simultaneous deletion of Bax and Bak is required to prevent apoptosis and interstitial fibrosis in obstructive nephropathy.

Authors:  Hee-Seong Jang; Babu J Padanilam
Journal:  Am J Physiol Renal Physiol       Date:  2015-07-15

5.  Autophagy drives fibroblast senescence through MTORC2 regulation.

Authors:  Monique Bernard; Bing Yang; Francis Migneault; Julie Turgeon; Mélanie Dieudé; Marc-Alexandre Olivier; Guillaume B Cardin; Mostafa El-Diwany; Katy Underwood; Francis Rodier; Marie-Josée Hébert
Journal:  Autophagy       Date:  2020-01-13       Impact factor: 16.016

6.  Caspase inhibition modulates left ventricular remodeling following myocardial infarction through cellular and extracellular mechanisms.

Authors:  William M Yarbrough; Rupak Mukherjee; Robert E Stroud; Evan C Meyer; G Patricia Escobar; Jeffrey A Sample; Jennifer W Hendrick; Joseph T Mingoia; Francis G Spinale
Journal:  J Cardiovasc Pharmacol       Date:  2010-04       Impact factor: 3.105

7.  Caspase-3 Is a Pivotal Regulator of Microvascular Rarefaction and Renal Fibrosis after Ischemia-Reperfusion Injury.

Authors:  Bing Yang; Shanshan Lan; Mélanie Dieudé; Jean-Paul Sabo-Vatasescu; Annie Karakeussian-Rimbaud; Julie Turgeon; Shijie Qi; Lakshman Gunaratnam; Natalie Patey; Marie-Josée Hébert
Journal:  J Am Soc Nephrol       Date:  2018-06-20       Impact factor: 10.121

8.  Novel mechanisms for caspase inhibition protecting cardiac function with chronic pressure overload.

Authors:  Misun Park; Stephen F Vatner; Lin Yan; Shumin Gao; Seunghun Yoon; Grace Jung Ah Lee; Lai-Hua Xie; Richard N Kitsis; Dorothy E Vatner
Journal:  Basic Res Cardiol       Date:  2013-01-01       Impact factor: 17.165

9.  Differential Apoptosis in Mucosal and Dermal Wound Healing.

Authors:  Ariel Johnson; Marybeth Francis; Luisa Ann DiPietro
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-12-01       Impact factor: 4.730

Review 10.  Type 2 immunity in tissue repair and fibrosis.

Authors:  Richard L Gieseck; Mark S Wilson; Thomas A Wynn
Journal:  Nat Rev Immunol       Date:  2017-08-30       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.